Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Roxane Laboratories has announced the approval of its abbreviated new drug application for Ramipril capsules, 1.25mg, 2.5mg, 5mg and 10mg by the FDA.
Subscribe to our email newsletter
Roxane Laboratories’s Ramipril capsules, 1.25mg, 2.5mg, 5mg and 10mg strengths will be available in various packaging configurations. These capsules are available for immediate shipment to wholesalers and pharmacies nationwide.
The Ramipril capsules are AB rated to Altace (ramipril) capsules. These capsules are indicated for the treatment of hypertension. It may be used alone or in combination with thiazide diuretics.